Clinician, Researcher, Public Health Scientist and Advocate for Patients
Home » Publications Authored by Dr. Younger » PANDAS: Baseline Immunoglobulin Levels Predict Achievement of Remission at One Year Following IVIg Therapy. David S. Younger et al. J Neurol Neurosurg 2016; 3(2):122.

PANDAS: Baseline Immunoglobulin Levels Predict Achievement of Remission at One Year Following IVIg Therapy. David S. Younger et al. J Neurol Neurosurg 2016; 3(2):122.

PANDAS: Baseline Immunoglobulin Levels Predict Achievement of Remission at One Year Following IVIg Therapy. David S. Younger et al. J Neurol Neurosurg 2016; 3(2):122.

Comment: In a large retrospective observational series of children with PANDAS treated with IVIg therapy, the children with low baseline total IgG and IgG subclass levels were the most likely to achieve remission of neuropsychiatric symptoms at 12-month follow-up. 

PDF: 
Pandas_Baseline_Immu.pdf